Skip to main content

Kris Venkat


Bangalore, India-based bioinformatics company Strand Genomics has appointed Kris Venkat to its board of directors. From 1992 to 2000, Venkat was chairman and CEO of biotech company Phyton. He is currently the chairman of Morphochem, Transvivo, Automated Cell, and Sundari Enterprises and is the co-founder and chairman of Accentua Pharma and Juelich Enzyme Products, both based in Germany.

Filed under

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.